APA (7th ed.) Citation

Martínez-Vila, C., Teixido, C., Martín, R., Aya, F., Sudhaman, S., Budde, G. L., . . . Arance, A. (2025). Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma. Cancers, 17(23), 3804. https://doi.org/10.3390/cancers17233804

Chicago Style (17th ed.) Citation

Martínez-Vila, Clara, et al. "Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma." Cancers 17, no. 23 (2025): 3804. https://doi.org/10.3390/cancers17233804.

MLA (9th ed.) Citation

Martínez-Vila, Clara, et al. "Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma." Cancers, vol. 17, no. 23, 2025, p. 3804, https://doi.org/10.3390/cancers17233804.